Jun 26, 2020 / 03:00PM GMT
Operator
Ladies and gentlemen, welcome to the Ultragenyx Pharmaceutical 2020 Annual Shareholder Meeting.
I will now turn things over to Chairman, Dan Welch.
Daniel G. Welch - Ultragenyx Pharmaceutical Inc. - Independent Non-Executive Chairman
Good morning, ladies and gentlemen, and welcome to the 2020 Annual Meeting of Stockholders of Ultragenyx Pharmaceutical Inc. My name is Dan Welch, and I serve as the Chairman of the Board. I'll be presiding over this meeting.
At this time, I call the meeting to order. Emil Kakkis, the President and CEO, is present and will walk us through the rest of the meeting. Emil?
Emil D. Kakkis - Ultragenyx Pharmaceutical Inc. - President, CEO & Director
Thank you, Dan. Joining us today are Bill Aliski, Chair of the Compensation Committee; Lars Ekman, Chair of the Research and Development Committee; Matt Fust, Chair of the Audit and Nominating and Corporate Governance Committee; Michael Narachi, Director; Shehnaaz Suliman, Director; Karah Parschauer, Executive Vice President
Ultragenyx Pharmaceutical Inc Annual Shareholders Meeting Transcript
Jun 26, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers